News

MitoSciences said that the tests, developed in collaboration with the University of Oregon, allow clinicians to identify adverse effects from drugs used to treat HIV/AIDS, hepatitis and other

Repligen said that the study is a double-blind, single ascending dose, Phase 1 study in healthy volunteers to evaluate the pharmacokinetic and safety profile of RG2833 in up

China Medicine has posted a net income of $1.79m for the first quarter of 2010, compared to $0.55m, for the prior year period. Income from operations was $1.24m,

NanoViricides said that under this agreement, Dr Rosenthal and coworkers are expected to evaluate the effectiveness of nanoviricides drug candidates against Herpes simplex virus 1 (HSV-1). Cell culture

Novavax said that it has produced a 2009 H1N1 influenza VLP vaccine and delivered it to the CDC in less than four weeks following the April 24, 2009

Eisai said that as there are currently few anti-arrhythmic agents with limited indications approved for pediatric use in Japan, arrhythmia has represented an area of unmet medical need

Health Decisions selected TrialMaster for its technology, its ability to deliver cost-effective operational efficiencies, and its interoperability with Health Decisions’ proprietary processes and software including Adaptive Monitoring, Adaptive

Genetic Immunity said that it has implemented ‘Quality-by-Design’ in biologic product development to manufacture a nanomedicine resulting in a new formulation of pDNA surrounded by a chemical polymer

Antares Pharma has posted a net loss of $1.6m for the first quarter 2010, or $0.02 per diluted share, compared to $2.78m, or $0.04 per diluted share, for